Association Between Antibiotic Exposure and Survival Among Patients Diagnosed With Advanced Melanoma or Advanced Non-Small Cell Lung Cancer (NSCLC) Treated With Immune Checkpoint Inhibitor (ICI) Therapy

被引：0
|
作者：
Reiss, S. [1 ]
Ascha, M. [1 ]
Yerram, P. [1 ]
Asfaw, A. A. [1 ]
Brake, S. [1 ]
Bouzit, L. [1 ]
Wade, N. B. [1 ]
机构：
[1] Flatiron Hlth, New York, NY USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
SA9
引用
收藏
页码：S499 / S499
页数：1
相关论文
共 50 条
  • [1] Impact of Brain Metastases in Immune Checkpoint Inhibitors (ICI) Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
    Hendriks, L.
    Henon, C.
    Auclin, E.
    Mezquita, L.
    Ferrara, R.
    Audigier-Valette, C.
    Mazieres, J.
    Lefebyre, C.
    Le Moulec, S.
    Cousin, S.
    Duchemann, B.
    Le Pechoux, C.
    Botticella, A.
    Ammari, S.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Planchard, D.
    De Ruysscher, D.
    Dingemans, A.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S384 - S384
  • [2] Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer
    Kichenadasse, Ganessan
    Miners, John O.
    Mangoni, Arduino A.
    Rowland, Andrew
    Hopkins, Ashley M.
    Sorich, Michael J.
    JAMA ONCOLOGY, 2020, 6 (04) : 512 - 518
  • [3] Association of Opioid Use with Survival in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitor Therapy
    Mock, J.
    Wynter, E.
    Young, P.
    Sytov, A.
    Elghawy, O.
    Gentzler, R.
    Novicoff, W.
    Martin, L.
    Hall, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S20 - S21
  • [4] Effect of antibiotic treatment on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer
    Alkan, G.
    Oztas, N. Senturk
    Turna, Z. H.
    Ozguroglu, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1082 - S1082
  • [5] Evaluating the role of race in outcome of advanced non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitor (ICI): Our institutional experience.
    Nazha, Bassel
    Chen, Zhengjia
    Goyal, Subir
    Engelhart, Anne
    Carlisle, Jennifer Wilkinson
    Beardslee, Tyler
    Gill, Harpaul
    Odikadze, Levani
    Liu, Yuan
    Mishra, Manoj K.
    Behera, Madhusmita
    Ramalingam, Suresh S.
    Owonikoko, Taofeek Kunle
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Use of immunosuppressive drugs (ISD) and the effectiveness of immune checkpoint inhibitor (ICI) therapy among patients with advanced/metastatic non-small cell lung cancer (NSCLC) in the United States (US)
    Dreyfus, Brian
    Zhang, Ellen Yan
    Doran, Charlotte
    Le, Kim
    Kola, C.
    Sylvester, Brooke E.
    Punekar, Rajeshwari
    Lal, Lincy
    Penrod, John
    Meadows-Shropshire, Stephanie L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 349 - 350
  • [7] Chronic immune checkpoint inhibitor (ICI) pneumonitis in patients (pts) with non-small cell lung cancer (NSCLC).
    Stuart, Jessica
    Ricciuti, Biagio
    Alessi, Joao Victor Machado
    Nishino, Mizuki
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
    Mezquita, Laura
    Auclin, Edouard
    Ferrara, Roberto
    Charrier, Melinda
    Remon, Jordi
    Planchard, David
    Ponce, Santiago
    Paz Ares, Luis
    Leroy, Laura
    Audigier-Valette, Clarisse
    Felip, Enriqueta
    Zeron-Medina, Jorge
    Garrido, Pilar
    Brosseau, Solenn
    Zalcman, Gerard
    Mazieres, Julien
    Caramela, Caroline
    Lahmar, Jihene
    Adam, Julien
    Chaput, Nathalie
    Soria, Jean Charles
    Besse, Benjamin
    JAMA ONCOLOGY, 2018, 4 (03) : 351 - 357
  • [9] Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancer
    Sumodhee, S.
    Guo, L.
    Bouhlel, L.
    Picard, A.
    Otto, J.
    Naghavi, A. O.
    Richier, Q.
    Levy, A.
    Bondiau, P-Y
    Poudenx, M.
    Passeron, T.
    Lacour, J-P
    Montaudie, H.
    Doyen, J.
    CANCER RADIOTHERAPIE, 2022, 26 (08): : 1045 - 1053
  • [10] Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors
    Zhao, Dan
    Mambetsariev, Isa
    Li, Haiqing
    Chen, Chen
    Fricke, Jeremy
    Fann, Patricia
    Kulkarni, Prakash
    Xing, Yan
    Lee, Peter
    Bild, Andrea
    Massarelli, Erminia
    Koczywas, Marianna
    Reckamp, Karen
    Salgia, Ravi
    CANCER RESEARCH, 2020, 80 (16)
12345